Role of MGMT as biomarker in colorectal cancer

by Inno, Alessandro, Fanetti, Giuseppe, Di Bartolomeo, Maria, Gori, Stefania, Maggi, Claudia, Cirillo, Massimo, Iacovelli, Roberto, Nichetti, Federico, Martinetti, Antonia, de Braud, Filippo, Bossi, Ilaria, Pietrantonio, Filippo
Published in World J Clin Cases (2014)

Gain of ALK Gene Copy Number May Predict Lack of Benefit from Anti-EGFR Treatment in Patients with Advanced Colorectal Cancer and RAS-RAF-PI3KCA Wild-Type Status

by Pietrantonio, Filippo, Maggi, Claudia, Di Bartolomeo, Maria, Facciorusso, Maria Grazia, Perrone, Federica, Testi, Adele, Iacovelli, Roberto, Miceli, Rosalba, Bossi, Ilaria, Leone, Giorgia, Milione, Massimo, Pelosi, Giuseppe, de Braud, Filippo
Published 2014

Role of cMET in the Development and Progression of Colorectal Cancer

by Pérez-Vargas, Juan Carlos Samamé, Biondani, Pamela, Maggi, Claudia, Gariboldi, Manuela, Gloghini, Annunziata, Inno, Alessandro, Volpi, Chiara Costanza, Gualeni, Ambra Vittoria, di Bartolomeo, Maria, de Braud, Filippo, Castano, Alessandra, Bossi, Ilaria, Pietrantonio, Filippo
Published 2013

Undetected Toxicity Risk in Pharmacogenetic Testing for Dihydropyrimidine Dehydrogenase

by Falvella, Felicia Stefania, Caporale, Marta, Cheli, Stefania, Martinetti, Antonia, Berenato, Rosa, Maggi, Claudia, Niger, Monica, Ricchini, Francesca, Bossi, Ilaria, Di Bartolomeo, Maria, Sottotetti, Elisa, Bernardi, Francesca Futura, de Braud, Filippo, Clementi, Emilio, Pietrantonio, Filippo
Published in Int J Mol Sci (2015)

DPD and UGT1A1 deficiency in colorectal cancer patients receiving triplet chemotherapy with fluoropyrimidines, oxaliplatin and irinotecan

by Falvella, Felicia Stefania, Cheli, Stefania, Martinetti, Antonia, Mazzali, Cristina, Iacovelli, Roberto, Maggi, Claudia, Gariboldi, Manuela, Pierotti, Marco Alessandro, Di Bartolomeo, Maria, Sottotetti, Elisa, Mennitto, Roberta, Bossi, Ilaria, de Braud, Filippo, Clementi, Emilio, Pietrantonio, Filippo
Published in Br J Clin Pharmacol (2015)

Single agent panitumumab in KRAS wild-type metastatic colorectal cancer patients following cetuximab-based regimens: Clinical outcome and biomarkers of efficacy

by Pietrantonio, Filippo, Perrone, Federica, Biondani, Pamela, Maggi, Claudia, Lampis, Andrea, Bertan, Claudia, Venturini, Filippo, Tondulli, Luca, Ferrari, Daris, Ricci, Vincenzo, Villa, Federica, Barone, Gloria, Bianco, Nadia, Ghidini, Antonio, Bossi, Ilaria, Fanetti, Giuseppe, Di Bartolomeo, Maria, de Braud, Filippo
Published 2013

FOLFOX-4 Chemotherapy for Patients With Unresectable or Relapsed Peritoneal Pseudomyxoma

by Pietrantonio, Filippo, Maggi, Claudia, Fanetti, Giuseppe, Iacovelli, Roberto, Di Bartolomeo, Maria, Ricchini, Francesca, Deraco, Marcello, Perrone, Federica, Baratti, Dario, Kusamura, Shigeki, Tamborini, Elena, Castano, Alessandra, Consonni, Paola Valentina, Bossi, Ilaria, Gavazzi, Cecilia, Milione, Massimo, Pelosi, Giuseppe, de Braud, Filippo
Published 2014

IL-8 and eNOS polymorphisms predict bevacizumab-based first line treatment outcomes in RAS mutant metastatic colorectal cancer patients

by Di Salvatore, Mariantonietta, Pietrantonio, Filippo, Orlandi, Armando, Del Re, Marzia, Berenato, Rosa, Rossi, Ernesto, Caporale, Marta, Guarino, Donatella, Martinetti, Antonia, Basso, Michele, Mennitto, Roberta, Santonocito, Concetta, Mennitto, Alessia, Schinzari, Giovanni, Bossi, Ilaria, Capoluongo, Ettore, Danesi, Romano, de Braud, Filippo, Barone, Carlo
Published in Oncotarget (2017)

GNAS mutations as prognostic biomarker in patients with relapsed peritoneal pseudomyxoma receiving metronomic capecitabine and bevacizumab: a clinical and translational study

by Pietrantonio, Filippo, Berenato, Rosa, Maggi, Claudia, Caporale, Marta, Milione, Massimo, Perrone, Federica, Tamborini, Elena, Baratti, Dario, Kusamura, Shigeki, Mariani, Luigi, Niger, Monica, Mennitto, Alessia, Gloghini, Annunziata, Bossi, Ilaria, Settanni, Giulio, Busico, Adele, Bagnoli, Pietro Francesco, Di Bartolomeo, Maria, Deraco, Marcello, de Braud, Filippo
Published in J Transl Med (2016)